News

The myMatrixx clinical pharmacy team has released an updated version of their Position Paper regarding COVID-19 Vaccination, Treatment and Coverage under Workers’ Compensation.

The myMatrixx team is excited to attend in-person once again and will have our own thought leaders presenting!

Phil Walls and The Hartford's Dr. Seidner share effective strategies for decreasing drug reliance

In today’s marketplace, trust and expertise help PBMs stand out - and myMatrixx is once again the Best-In-Class PBM

myMatrixx Chief Client Officer, Paul King, continues the conversation on the power of trust.

myMatrixx Chief Sales Officer, David Dubrof, discusses how PBMs should be working to build trust with clients from day one.

The U.S. Food and Drug Administration (FDA) fully approved the first vaccine for active prevention of COVID-19 in individuals 16 years of age and older.

myMatrixx parent company Cigna has established new requirements to help protect its workforce.

A recent post from a myMatrixx client highlights our ongoing partnership to deliver safe and cost-effective drug therapy through careful prescription monitoring.

On August 12, 2021, the FDA updated the Emergency Use Authorization (EUA) for the COVID-19 vaccines from Moderna and Pfizer/BioNTech.